GH1 and Obesity: In this obesity model, the animals MSG-treated presented an imbalance in the hypothalamic-pituitary-adrenocortical (HPA) axis and among several endocrine changes, Ranke et al. (1988) [26] reported a decreased production of growth hormone (hyposomatotropism).